Schnitzer TJ - Search Results

1

Osteoporosis treatment for patients with stroke.

Greenberg JA, Roth EJ, Wuermser LA, Almagor O, Schnitzer TJ. Greenberg JA, et al. Among authors: schnitzer tj. Top Stroke Rehabil. 2007 Mar-Apr;14(2):62-7. doi: 10.1310/tsr1402-62. Top Stroke Rehabil. 2007. PMID: 17517576

2

Prevalence of 25-hydroxyvitamin D deficiency in the outpatient rehabilitation population.

Pellicane AJ, Wysocki NM, Schnitzer TJ. Pellicane AJ, et al. Among authors: schnitzer tj. Am J Phys Med Rehabil. 2010 Nov;89(11):899-904. doi: 10.1097/PHM.0b013e3181f71112. Am J Phys Med Rehabil. 2010. PMID: 20962600

3

Bone mineral density in patients with stroke: relationship with motor impairment and functional mobility.

Schnitzer TJ, Harvey RL, Nack SH, Supanwanid P, Maskala-Streff L, Roth E. Schnitzer TJ, et al. Top Stroke Rehabil. 2012 Sep-Oct;19(5):436-43. doi: 10.1310/tsr1905-436. Top Stroke Rehabil. 2012. PMID: 22982831

4

Update on alendronate for osteoporosis: once-weekly dosing.

Schnitzer TJ. Schnitzer TJ. Expert Opin Pharmacother. 2001 Sep;2(9):1461-72. doi: 10.1517/14656566.2.9.1461. Expert Opin Pharmacother. 2001. PMID: 11585024 Review.

5

Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.

Schnitzer TJ, Kong SX, Mavros PP, Straus WL, Watson DJ. Schnitzer TJ, et al. Clin Ther. 2001 Dec;23(12):1984-98. doi: 10.1016/s0149-2918(01)80151-x. Clin Ther. 2001. PMID: 11813933

6

An observational, retrospective, cohort study of dosing patterns for rofecoxib and celecoxib in the treatment of arthritis.

Schnitzer TJ, Kong SX, Mitchell JH, Mavros P, Watson DJ, Pellissier JM, Straus WL. Schnitzer TJ, et al. Clin Ther. 2003 Dec;25(12):3162-72. doi: 10.1016/s0149-2918(03)90100-7. Clin Ther. 2003. PMID: 14749154

7

Calcaneal quantitative ultrasound compared with hip and femoral neck dual-energy x-ray absorptiometry in people with a spinal cord injury.

Schnitzer TJ, Wysocki N, Barkema D, Griffith J, Lent V, Romba M, Welbel R, Bhuva S, Manyam B, Linn S. Schnitzer TJ, et al. PM R. 2012 Oct;4(10):748-55. doi: 10.1016/j.pmrj.2012.05.011. Epub 2012 Jul 28. PM R. 2012. PMID: 22841967

8

Effect of parathyroid hormone combined with gait training on bone density and bone architecture in people with chronic spinal cord injury.

Gordon KE, Wald MJ, Schnitzer TJ. Gordon KE, et al. Among authors: schnitzer tj. PM R. 2013 Aug;5(8):663-71. doi: 10.1016/j.pmrj.2013.03.032. Epub 2013 Apr 1. PM R. 2013. PMID: 23558091

9

Zoledronic Acid Treatment After Acute Spinal Cord Injury: Results of a Randomized, Placebo-Controlled Pilot Trial.

Schnitzer TJ, Kim K, Marks J, Yeasted R, Simonian N, Chen D. Schnitzer TJ, et al. PM R. 2016 Sep;8(9):833-43. doi: 10.1016/j.pmrj.2016.01.012. Epub 2016 Jan 30. PM R. 2016. PMID: 26828618 Clinical Trial.

10

Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density.

Haider IT, Simonian N, Saini AS, Leung FM, Edwards WB, Schnitzer TJ. Haider IT, et al. Among authors: schnitzer tj. Spinal Cord. 2019 Oct;57(10):832-842. doi: 10.1038/s41393-019-0303-3. Epub 2019 Jun 4. Spinal Cord. 2019. PMID: 31164732 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters